Background: Articular involvement is frequent in Systemic Sclerosis. Joint symptoms have been noted in 24-97% of patients at some time during the course of their illness. Musculoskeletal Ultrasound and Magnetic Resonance Imaging can identify and characterize subclinical synovial inflammation as well as overt joint damage in Systemic Sclerosis. Aim of Study: To evaluate the role of Musculoskeletal Ultrasound and Magnetic Resonance Imaging in early detection of inflammatory arthropathy in patients with Systemic Sclerosis and to correlate the radiological findings with various disease parameters. Patients and Methods: 20 patients with Systemic Sclerosis and arthralgia, with no evidence of clinical or laboratory features of overlap syndromes (including Rheumatoid Factor or Anti CCP) or evidence of clinically swollen or tender joints, were subjected to clinical and immunological evaluation. Musculoskeletal ultrasonography and Magnetic resonance imaging were done for tenosynovitis, synovitis and erosions, with MRI representing the standard reference method. Results: Musculoskeletal ultrasound detected tenosynovitis in 55%, synovitis in 50% and erosions in 35% of patients as compared to Magnetic resonance which detected tenosynovitis in 80%, synovitis in 75% and erosions in 55% of the patients with a percentage of agreement of 72%, 64% and 60% for tensosynovitis, synovitis and erosions respectively. Tenosynovitis and synovitis showed a significant positive correlation with ESR (r=0.44) and CRP (r=0.53) and erosions correlated significantly with the disease duration (r=0.63). Conclusion: Inflammatory arthropathy and erosive changes are present in a high percentage of systemic sclerosis patients. Tenosynovitis and synovitis correlate with systemic inflammatory markers. Both musculoskeletal ultrasound and magnetic resonance imaging are useful in characterizing early inflammatory arthropathy in systemic sclerosis patients.
INTRODUCTION
Systemic Sclerosis (SSc) is a connective tissue disease characterized by vascular, immune and fibrotic changes in the skin and internal organs. The majority of patients with SSc develop musculoskeletal symptoms during the course of their illness. Manifestations may include varying degrees of rheumatic complaints ranging from arthralgia to frank arthritis, and with progression of the disease, debilitating contractures may occur. 1 Joint involvement may be an initial manifestation that precedes the onset of Raynaulds phenomenon or may arise concomitantly and therefore might be considered an early indicator of SSc. The frequency of joint involvement as an initial sign of SSc has not been defined accurately and ranges from 12% to 66% of SSc patients. 2 Recent cohort studies examining clinical and radiographic aspects of SSc have clarified the frequency of articular involvement and identified For Correspondence: reemhabeeb@yahoo.com subsets of SSc patients with a higher risk of developing joint involvement. They have also highlighted the potential contribution of inflammatory arthritis to early SSc. Some pilot studies have underlined the potential usefulness of Musculoskeletal ultrasonography (MSUS) and Magnetic resonance imaging (MRI) for a better evaluation of joint involvement in SSc. 3 Furthermore, Erosive joint damage has been reported in SSc patients and has been attributed to overlap with mixed Connective tissue disease or Rheumatoid arthritis. MSUS and MRI can identify and characterize subclinical synovial inflammation as well as overt joint damage in SSc patients with much greater precision than X-ray. 4 
Aim of The Work:
The aim of this study was to evaluate the role of MSUS and MRI in early detection of inflammatory arthropathy in patients with SSc and to correlate the radiological findings with various disease parameters.
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PATIENTS AND METHODS
This study was conducted on 20 patients, diagnosed with systemic sclerosis according to the 2013 American Colleague of Rheumatology/European League Against Rheumatism Systemic Sclerosis classification criteria. 5 Patients were attending the Rheumatology outpatient clinic and the inpatient ward of Internal Medicine department at Ain Shams University Hospital. Informed consents were obtained from the patients and the study was approved by Ain Shams Medical ethics committee.
All patients were subjected to the following: -Full history taking and thorough clinical and musculoskeletal examination: -All patients were selected with arthralgia with no evidence of clinically swollen or tender joints, and patients with clinical or laboratory features of overlap syndromes (including Rheumatoid Factor or Anti CCP) were excluded from the study. 
Radiological Evaluation:
Musculoskeletal Ultrasonography: Performed using a General Electric LOGIQ 500 unit (General Electric, Solingen, Germany) using a 7-13 MHz linear array transducer. Joints were examined by an expert radiologist with a rheumatological background, blinded to the diagnosis and clinical data. Bilateral 2 nd to 5 th metacarpo phalangeal (MCP), proximal interphalangeal (PIP), distal interphalangeal (DIP) joints were assessed, as well as the distal radioulnar and radiocarpal joints, inter-carpal and carpometacarpal joints. Tendons (extensor and flexors of the hands and fingers at the level of the wrists and hands) were also examined using a multiplanar and dynamic scanning technique. All explored joints and tendons were evaluated for the presence of synovial hypertrophy on grey scale and synovitis/tenosynovitis on power Doppler ultrasonography, according to OMERACT definitions criteria. 6 The following values of Doppler settings were used: frequency 7.5 MHz, low wall filter, pulse repetition frequency ranging from 700 to 1000 Hz and the maximal gain level not generating artifacts signal below the bony cortex. Bones were examined for erosions, defined as a cortical "break" or defect seen in longitudinal and transverse planes.
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Magnetic Resonance Imaging:
Examination of the wrists and hands was performed using a 1.5 Tesla MR scanner (Achieva; Philips Medical Systems, Bothell, WA, USA). The following conventional pulse sequences were used for all patients: Coronal and axial T1-weighted and T2-weighted fast spin echo, coronal short inversion time inversion-recovery (STIR) and contrast-enhanced coronal and axial T1-weighted sequence with fat suppression. The TR/TE values used in T1-and T2-weighted imaging were 424/10 and 3000/100, respectively, while STIR images were obtained by using 3761/80 ( TR/TE). Other key imaging parameters acquired were as follows: slice thickness, 3 mm; flip angle 10°; field of view (FOV) 250 mm. MRI images were assessed by a musculoskeletal radiologist (blinded to the diagnosis, clinical data and ultrasound findings) for the presence of synovitis, tenosynovitis, bone marrow edema, and erosions. MRI images were considered the standard reference for confirming the presence of these lesions.
Statistical Analysis
Statistical analysis was performed using SPSS for Windows version 17.0, two-tailed tests were used. Descriptive statistics of the range, means, and standard deviation were calculated for interval and ordinary variables and frequencies and percentages for categorical variables, correlations were bivariate correlations procedure computes Pearson's correlation and percentage of agreement. For all tests P value > 0.05 was insignificant and P <0.05 was significant.
RESULTS
This study was conducted on 20 patients diagnosed as systemic sclerosis. There were 4 males (20%) and 16 females (80%). Their mean age was 37.3 years (range 32-53 years) and their mean disease duration was 8.7 years (range 6-19 years). Table ( 2) shows the ultrasonographic findings in patients. MSUS was able to detect tenosynovitis ( Figure 2 A and B) in 11 patients (55%), and synovitis ( Figure 3 A and B) in 10 patients (50%). Erosions were found in 7 patients (35 %) while bone marrow edema was not depicted on US at all ( Figure 4C ). Figure 2C ) in 16 patients (80%), and synovitis ( Figure 3C ) in 15 patients (75%), erosions in 11 patients (55%) and bone marrow edema in 13 patients (65%) ( Figure 4A ).
Ultrasound Findings
MRI Findings
Comparison between MSUS and MRI
Table (4) shows the comparison between MSUS and MRI in detecting tenosynovitis, synovitis and erosions. MRI detected tenosynovitis and synovitis in 5 more patients than MSUS (25%) ( Figure 5 ) and erosions in 4 more patients. 
DISCUSSION
Joint symptoms have been noted in 12-66% of patients with systemic Sclerosis (SSc) at the time of diagnosis and in 24-97% of patients at some time during the course of their illness. Many radiological changes in the joints of SSc patients have been identified but erosive arthropathy is considered uncommon. 8 Relatively few studies have examined the role of Musculoskeletal Ultrasonography (MSUS) and Magnetic Resonance Imaging (MRI) in the characterization of joint involvement in patients with SSc. 9 In this study, MSUS and MRI were used to evaluate early inflammatory arthropathy in patients with SSc. The study included 20 patients with SSc, 4 males (20%) and 16 females (80%), mean age was 37.3 years (range 32-53 years) and mean disease duration was 8.7 years (range 6-19 years). All patients had arthralgia with no evidence of clinically swollen or tender joints. All patients were Rheumatoid factor (RF) and Anti CCP negative, ANA was positive in 95% of patients, CRP in 70% and the mean ESR was 37.324.16.
In this study, MSUS detected tenosynovitis in 55%, synovitis in 50% and erosions in 35% of patients as compared to MRI which detected tenosynovitis in 80%, synovitis in 75% and erosions in 55% of the patients. Recently, several surveys described a high frequency of musculoskeletal symptoms in patients with SSc. 10, 11 One study after assessing 45 consecutive patients with SSc for osteoarticular involvement using ultrasonography, stated that the prevalence of synovitis detected with ultrasound was significantly higher than that found by clinical examination. (26 vs 15 out of 45 cases, P = 0.03). 12 In addition florid inflammatory changes with MRI have been reported in a significant proportion of symptomatic SSc patients, where inflammatory joint disease of the hand was assessed by MRI in 17 patients with a history of joint pain or swelling. Ten patients had inflammatory MRI findings with synovitis (n = 8), joint effusion (n = 7) or tenosynovitis (n = 8). 13 However, their study cohort included patients with clinically swollen joints and positive serology for RF suggesting inclusion of patients with features of Rheumatoid arthritis overlap, which in contrast to this study, where at the time of assessment, the exclusion of patients with positive RF and anti CCP serology or clinically swollen joints allowed a reasonable assumption that our cohort did not include patients with features of overlap syndrome.
Relatively few studies however have compared between MSUS and MRI in the detection of inflammatory arthropathy in SSc patients. One study including 13 SSc patients with arthralgia and no overt inflammatory arthritis had MSUS of their hands. 8 of these 13 patients also had MRI with gadolinium of their most symptomatic hand. Of the eight patients undergoing MRI scan, 100% of the patients had synovitis and 88% of patients had tenosynovitis. MRI also showed erosions in 75% of patients. With MSUS, tenosynovitis was seen in 47% of the patients and synovitis in 23%, no erosions were identified. Comparison between MSUS and MRI showed 38%, 62% and 25% percentage agreement for tenosynovitis, synovitis and erosions respectively. 2 In agreement, a recent study of 16 SSc patients compared MSUS and MRI in detecting synovial inflammation in SSc. With MSUS, tenosynovitis was detected in 7 (43.7 %) patients and synovitis in 5 (31 %) patients and erosions in 1 (6.3%), Regarding MRI, 81.3 % (13) patients had tenosynovitis, 87.5 % (14) patients had synovitis. and 62.5 % (10) patients had erosions.
Comparison between MSUS and MRI showed 62%, 43% and 45% percentage agreement for tenosynovitis, synovitis and erosions respectively. The study concluded that while both MRI and MSUS are useful in characterizing synovial inflammation in SSc, MRI is clearly more sensitive than MSUS in this setting. 4 In comparison with the previous two studies our results were somewhat similar as regard comparing MSUS and MRI for tenosynovitis and synovitis with a percentage agreement of 66% and 64% respectively. However our results for Erosions showed a higher percentage agreement 60%, as compared to 25% and 45% in the previous two studies. The higher percentage of erosions detected by MSUS in this study could be explained by the wide availability of high resolution ultrasound equipment now available. In addition, bone erosions detected by MSUS and MRI in the present study showed a significant positive correlation with disease duration which could have influenced our findings.
In agreement with the present study, another study reported erosions in 53% of patients with SSc studied by ultrasonography.
14 Furthermore erosive arthropathy had been detected in 24 of 46 of SSc cases in a prior study. 15 On the other hand however in two studies using MRI, hand erosions were detected in 16% (6/38) and 41% (7/17) of SSc patients. 13 16 Furthermore in one prospective cohort study involving 120 patients, erosive arthritis was found in only 22 (18%) of SSc patients 17 and in another longitudinal study, erosive arthritis of the hand was found in only one fourth of SSc patients. 18 Review of the literature has revealed studies comparing sonography and MRI in erosive joint diseases. Alarcon and coworkers and Lopez-Ben and colleagues reported that ultrasonography had high accuracy, with MRI as the reference method, in the second and fifth MCP joints. 19, 20 In a group of patients with nonerosive RA on conventional radiography, Magnani and coworkers even visualized significantly more erosions in patients' MCP joints with ultrasonography than with MRI. 21 Scheel et al found that ultrasound was superior to MRI in detecting erosions in the proximal interphalangeal joints but was less efficient at the metacarpo-phalangeal joints. 22 However , It is important to mention that one of the earliest MRI signs of erosion is subchondral bone oedema, and there are, as yet, no studies to show that ultrasound is useful in detecting this. Ultrasound is not capable of appreciating intraosseous abnormalities that are not associated with an overlying surface defect. 23 Several studies have correlated between the synovitis detected in SSc patients by MSUS and MRI, and acute phase reactants. In this study tenosynovitis and synovitis correlated significantly with ESR and CRP (P<0.05) and erosions correlated significantly with disease duration (P<0.05). These results were similar to a study that identified an association between synovitis and elevated ESR (≥28 mm/h) and CRP (≥10 mg/l), suggesting that joint involvement might be associated with systemic inflammation in SSc. 11 Furthermore in another multiple logistic regression analysis, higher ESR, age more than 38 and disease duration more than 10 years were risk factors for the occurrence of erosions. 8 On the other hand however, other studies although reporting a high prevalence of joint inflammatory findings including synovitis, tenosynovitis and erosions in 17 symptomatic SSC patients undergoing MRI, yet they stated that the MRI findings did not correlate with any clinical or laboratory evidence of inflammation. 13 In conclusion the current literature has shown that both ultrasound and MRI depicted musculoskeletal involvement in a considerable number of patients with systemic sclerosis, who showed no clinical evidence of inflammatory arthropathy. Advantages of MSUS over MRI include the ability to demonstrate angioneogenesis in active synovitis directly, whereas MRI requires injection of contrast medium. MSUS is a dynamic technique, with the ability to carry out rapid assessment of many widely spaced joints and to move and stress musculoskeletal structures. 23 Unlike MRI, MSUS is readily suited to guiding intervention, such as small joint injection or synovial biopsy. There is also increasing evidence that patients prefer ultrasound to MRI. This may be related to claustrophobia but equally to the human interaction that occurs during an ultrasound examination, let alone the financial burden of a Post Contrast MRI study compared to a simple MSUS.
Conversely, ultrasound is a relatively timeconsuming procedure, especially if multiple joints are examined. There is no ability to identify abnormalities overlooked and not imaged at the time of the original examination. Meanwhile, MRI has a higher sensitivity in detecting lesions, as well as a unique ability to display high resolution images, which can be obtained remotely, reviewed, re-read and scored at a later date and preserved for serial comparison.
Finally, given the burden of arthralgia and arthritis in SSc, randomized controlled trials are needed to evaluate associated joint involvement in SSc patients. In such trials, MSUS and MRI may be of major potential benefit in patient evaluation, where early detection and precise characterization of musculoskeletal involvement in such patients may be of good prognostic value.
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